6533b7d4fe1ef96bd1262ab2
RESEARCH PRODUCT
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort
A. D'arminio MonforteA. TavelliA. Cozzi-lepriA. CastagnaS. PasseriniD. FrancisciA. SaracinoF. MaggioloG. LapadulaE. GirardiC. F. PernoA. AntinoriA. D'arminio MonforteA. AntinoriM. AndreoniA. CastagnaF. CastelliR. CaudaG. Di PerriM. GalliR. IardinoG. IppolitoA. LazzarinG. C. MarchettiG. RezzaF. Von SchloesserP. VialeA. D'arminio MonforteA. AntinoriA. CastagnaF. Ceccherini-silbersteinA. Cozzi-lepriE. GirardiS. Lo CaputoC. MussiniM. PuotiC. F. PernoA. AntinoriF. BaiC. BalottaA. BanderaS. BonoraM. BorderiA. CalcagnoA. CapettiM. R. CapobianchiA. CastagnaF. Ceccherini-silbersteinS. CicaliniA. CingolaniP. CinqueA. Cozzi-lepriA. D'arminio MonforteA. De LucaA. Di BiagioE. GirardiN. GianottiA. GoriG. GuaraldiG. LapadulaM. LichtnerS. Lo CaputoG. MadedduF. MaggioloG. MarchettiL. MonnoC. MussiniS. NozzaC. F. PernoC. PinnettiM. PuotiE. Quiros RoldanR. RossottiS. RusconiM. M. SantoroA. SaracinoL. SarmatiA. Cozzi-lepriI. FantiL. GalliP. LorenziniA. RodanoM. MacchiaA. TavelliF. CarlettiS. CarraraA. Di CaroS. GrazianoF. PetroniG. ProtaS. TruffaA. GiacomettiA. CostantiniV. BarocciG. AngaranoL. MonnoE. MilanoF. MaggioloC. SuardiP. VialeV. DonatiG. VerucchiF. CastelnuovoC. MinardiE. Quiros RoldanB. MenzaghiC. AbeliB. CacopardoB. CelesiaJ. VecchietK. FalascaA. PanS. LorenzottiL. SighinolfiD. SegalaP. BlancF. VichiG. CassolaC. ViscoliA. AlessandriniN. BobbioG. MazzarelloM. LichtnerL. FondacoP. BonfantiC. MolteniA. ChioderaP. MiliniG. NunnariG. PellicanoA. D'arminio MonforteM. GalliA. LazzarinG. RizzardiniM. PuotiA. CastagnaE. S. CannizzoM. C. MoioliR. PioliniD. BernacchiaS. SalpietroC. TincatiC. MussiniC. PuzzolanteC. MigliorinoG. LapadulaV. SangiovanniG. BorgiaV. EspositoG. Di FlumeriI. GentileV. RizzoA. M. CattelanS. MarinelloA. CascioM. TrizzinoD. FrancisciE. SchiaroliG. ParrutiF. SozioG. MagnaniM. A. UrsittiM. AndreoniA. AntinoriR. CaudaA. CristaudoV. VulloR. AcinapuraD. MoscheseM. CapozziA. MondiA. CingolaniM. Rivano CapparucciaG. IaianiA. LatiniR. GagliardiniM. M. PlazziG. De GirolamoA. VergoriM. CecchettoF. VivianiG. MadedduA. De VitoB. RossettiF. MontagnaniA. FrancoR. Fontana Del VecchioC. Di GiuliP. CaramelloG. Di PerriS. BonoraG. C. OrofinoM. SciandraM. BassettiA. LonderoV. ManfrinG. BattaginG. StarniniA. Ialungosubject
0301 basic medicinediagnosishivcommunicable diseasesHIV InfectionsLogistic regressionVirological responseCohort Studies0302 clinical medicineRetention in CareMedicinePharmacology (medical)HIV Infection030212 general & internal medicineProspective cohort studycd4 count determination proceduredrugsuppressionViral LoadCD4 Lymphocyte Count; Cohort Studies; Humans; Italy; Viral Load; Anti-HIV Agents; HIV Infections; Retention in CarevirologyInfectious DiseasesItalyblood hiv rnaCohorthiv cd4 count determination procedure communicable diseases incomeitaly diagnosis virology blood hiv rna retention in careincomeitalyViral loadHIV ARTCohort studyHumanMicrobiology (medical)medicine.medical_specialtyAnti-HIV Agentsantiretroviral therapySettore MED/17 - MALATTIE INFETTIVENO03 medical and health sciencesHIV viral loadInternal medicineHumansHIV CD4 ARTPharmacologybusiness.industrydouble blindAnti-HIV AgentHIV viral load antiretroviral therapy double blind initiation suppression infectionRetention in care030112 virologyinfectioninitiationCD4 Lymphocyte CountObservational studyCohort Studiebusinessdescription
Abstract Objectives To describe: (i) factors associated with rapid and delayed ART initiation; (ii) rates of 12 week virological response; and (iii) virologically controlled retention in care by 1 year from ART initiation according to timing of start in a real-life setting. Methods All individuals in the Icona cohort diagnosed with HIV in 2016–17 who initiated ART were grouped according to the time between HIV diagnosis and ART initiation: Group 1, ≤7 days; Group 2, 8–14 days; Group 3, 15–30 days; Group 4, 31–120 days; and Group 5, >120 days. Multivariable logistic regression models were used to identify factors associated with: (i) the probability of rapid (Group 1) and very delayed (Group 5) ART initiation; (ii) the 12 week virological response (by a modified snapshot algorithm); and (iii) the probability of retention in care at 1 year (on ART with HIV-RNA <50 copies/mL). Results A total of 1247 individuals were included [82 (6.6%) in Group 1, 115 (9.2%) in Group 2, 267 (21.4%) in Group 3, 641 (51.4%) in Group 4 and 142 (11.4%) in Group 5]. Main predictors of rapid ART start (Group 1) were low CD4 cell count and high HIV-RNA at first contact with the infectious diseases centre. There was no association between probability of virological response and timing of ART initiation. Overall, 90% of individuals remained on ART after 1 year, 91% with undetectable HIV-RNA. Participants of Italian nationality, those with higher CD4 cell count and lower HIV-RNA at ART initiation were more likely to be retained in care after 1 year. Conclusions In our high-income observational setting, we did not observe differences in the 1 year rate of virological response and retention in care according to timing of ART initiation.
year | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 |